EvokAI Creative Labs Inc. (OKAI) - Net Assets
Based on the latest financial reports, EvokAI Creative Labs Inc. (OKAI) has net assets worth CA$-976.91K CAD as of September 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$79.22K) and total liabilities (CA$1.06 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-976.91K |
| % of Total Assets | -1233.19% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
EvokAI Creative Labs Inc. - Net Assets Trend (2021–2023)
This chart illustrates how EvokAI Creative Labs Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for EvokAI Creative Labs Inc. (2021–2023)
The table below shows the annual net assets of EvokAI Creative Labs Inc. from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | CA$-284.34K | +56.93% |
| 2022-12-31 | CA$-660.15K | -1292.95% |
| 2021-12-31 | CA$55.34K | -- |
Equity Component Analysis
This analysis shows how different components contribute to EvokAI Creative Labs Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1779873700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$21.10 Million | % |
| Total Equity | CA$-284.34K | 100.00% |
EvokAI Creative Labs Inc. Competitors by Market Cap
The table below lists competitors of EvokAI Creative Labs Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO
|
$633.08K |
|
Portofino Resources Inc
V:POR
|
$634.57K |
|
Spermosens AB (publ)
F:9R5
|
$634.60K |
|
AWY0
F:AWY0
|
$635.66K |
|
Panthera Resources PLC
LSE:PAT
|
$628.16K |
|
Schroder British Opportunities Trus
LSE:SBO
|
$627.16K |
|
International Bethlehem Mining Corp
V:IBC-H
|
$627.12K |
|
Newtopia Inc
V:NEWU
|
$626.69K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in EvokAI Creative Labs Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -660,152 to -284,337, a change of 375,815.
- Net loss of 17,083,353 reduced equity.
- Other factors increased equity by 17,459,168.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-17.08 Million | -6008.14% |
| Other Changes | CA$17.46 Million | +6140.31% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares EvokAI Creative Labs Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | CA$0.01 | CA$0.12 | x |
| 2022-12-31 | CA$-0.01 | CA$0.12 | x |
| 2023-12-31 | CA$-0.04 | CA$0.12 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently EvokAI Creative Labs Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-51.85%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -155.55% | 0.00% | 0.00x | 1.00x | CA$-91.61K |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | CA$-649.37K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | CA$-17.05 Million |
Industry Comparison
This section compares EvokAI Creative Labs Inc.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,147,097
- Average return on equity (ROE) among peers: -31.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| EvokAI Creative Labs Inc. (OKAI) | CA$-976.91K | -155.55% | N/A | $632.70K |
| Diagnos Inc (ADK) | $-1.95 Million | 0.00% | 0.00x | $18.42 Million |
| NetraMark Holdings Inc. (AIAI) | $1.83 Million | -284.61% | 0.19x | $61.38 Million |
| Comprehensive Healthcare Systems Inc (CHS) | $316.65K | -33.71% | 0.02x | $12.07 Million |
| Carespan Health Inc (CSPN) | $-699.52K | 0.00% | 0.00x | $688.89K |
| CardioComm Solutions Inc. (EKG) | $489.32K | 8.09% | 2.15x | $1.43 Million |
| Kovo Healthtech Corp (KOVO) | $-614.00K | 0.00% | 0.00x | $1.28 Million |
| Kneat.com Inc (KSI) | $14.80 Million | -4.46% | 0.02x | $295.86 Million |
| Newtopia Inc (NEWU) | $-1.84 Million | 0.00% | 0.00x | $626.69K |
| Hydreight Technologies Inc (NURS) | $-784.54K | 0.00% | 0.00x | $135.22 Million |
| NexgenRX Inc. (NXG) | $-83.93K | 0.00% | 0.00x | $20.06 Million |
About EvokAI Creative Labs Inc.
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company's artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel m… Read more